title: Heart rate and the cardiometabolic risk.
abstract: Resting heart rate is a well recognized marker of autonomic nervous system tone, and in many population studies has been found to be a significant correlate of blood pressure, increased body mass index, and metabolic disturbances. This association is particularly striking in patients with hypertension or diabetes, and cardiovascular morbidity related to high heart rate in these conditions seems to depend mainly on the clustering of these risk factors. The prospective relationship between tachycardia and metabolic abnormalities found in longitudinal studies indicates that the adrenergic overdrive is the cause rather than the consequence of the insulin resistance state. Findings from observational studies and clinical trials have shown that heart rate measured during the follow-up provides prognostic information over and above heart rate measured at baseline, whereas the predictive value of heart rate measured out of the office is still debated. Antihypertensive drugs that decrease blood pressure and heart rate through a reduction of the sympathetic outflow may be more beneficial in clinical situations characterized by heightened sympathetic activity associated to insulin resistance.
authors: Dipartimento di Medicina, University of Padova, via Giustiniani, 2, 35128, Padova, Italy. palatini@ux1.unipd.it
authors: Paolo
authors: P
authors: Palatini
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000503:physiopathology*; D003920:Diabetes Mellitus / Q000175:diagnosis / Q000188:drug therapy; D006339:Heart Rate / Q000502:physiology*; D006801:Humans; D024821:Metabolic Syndrome / Q000503:physiopathology*; D012306:Risk
chemical_list: D000959:Antihypertensive Agents
references: PLoS One. 2012;7(12):e51101
references: 23284659
references: N Engl J Med. 2010 Sep 2;363(10):905-17
references: 20818901
references: Am J Cardiol. 2009 Jan 15;103(2):279-83
references: 19121452
references: Dtsch Med Wochenschr. 2012 Dec;137(50):2631-6
references: 23225186
references: Prog Cardiovasc Dis. 2009 Jul-Aug;52(1):31-7
references: 19615491
references: J Am Coll Cardiol. 2009 Sep 22;54(13):1154-61
references: 19761936
references: Am J Hypertens. 2004 Nov;17(11 Pt 1):1005-10
references: 15533725
references: Eur Heart J. 2010 Sep;31(18):2271-9
references: 20601389
references: Am J Hypertens. 2009 Feb;22(2):151-5
references: 19151693
references: Hypertension. 2003 Oct;42(4):474-80
references: 12953019
references: Obesity (Silver Spring). 2011 Mar;19(3):618-23
references: 20814417
references: J Diabetes Complications. 2003 Jul-Aug;17(4):169-78
references: 12810239
references: Int J Sports Med. 2012 Sep;33(9):683-90
references: 22562742
references: Eur Heart J. 2010 Dec;31(24):3040-5
references: 20935002
references: Hypertension. 2011 Nov;58(5):745-50
references: 21896939
references: Int J Cardiol. 2010 May 28;141(2):122-31
references: 19910061
references: JAMA. 2004 Nov 10;292(18):2227-36
references: 15536109
references: Hypertension. 1997 Nov;30(5):1267-73
references: 9369286
references: Clin Res Cardiol. 2007 Sep;96(9):585-92
references: 17593316
references: J Hypertens. 2006 Apr;24(4):603-10
references: 16531784
references: Diabetes Care. 2008 Feb;31(2):335-9
references: 17959868
references: Eur Heart J. 2009 Jan;30(2):225-32
references: 19074443
references: J Hypertens. 2004 Oct;22(10):1999-2006
references: 15361773
references: Exp Clin Endocrinol Diabetes. 2003 Jun;111(4):215-22
references: 12845560
references: Hypertension. 2010 Feb;55(2):567-74
references: 20038750
references: Lancet. 2010 Sep 11;376(9744):875-85
references: 20801500
references: J Hum Hypertens. 2013 Jul;27(7):412-6
references: 23235366
references: J Am Coll Cardiol. 2010 Mar 2;55(9):931; author reply 931-2
references: 20185050
references: J Am Coll Cardiol. 2012 Dec 25;60(25):2643-50
references: 23177297
references: Hypertension. 1987 Feb;9(2):209-15
references: 3818018
references: Circulation. 2005 Apr 12;111(14):1777-83
references: 15809377
references: Prog Cardiovasc Dis. 2009 Jul-Aug;52(1):46-60
references: 19615493
references: J Hypertens. 2000 Jun;18(6):769-75
references: 10872563
references: Ann Intern Med. 1967 Jul;67(1):48-59
references: 6028658
references: Hypertension. 2008 Aug;52(2):229-35
references: 18574073
references: Nat Rev Cardiol. 2011 Apr 26;8(7):369-79
references: 21519356
references: Hypertension. 2007 Jan;49(1):40-7
references: 17130308
references: Am J Hypertens. 2011 Jul;24(7):783-8
references: 21451592
references: J Hum Hypertens. 2008 Feb;22(2):75-82
references: 17882228
references: Curr Opin Nephrol Hypertens. 2004 Sep;13(5):513-9
references: 15300157
references: J Hypertens. 2007 May;25(5):909-20
references: 17414649
references: J Hypertens. 2008 Aug;26(8):1571-6
references: 18622234
references: J Hypertens. 2006 Jul;24(7):1375-81
references: 16794487
references: J Hypertens. 2006 Sep;24(9):1873-80
references: 16915038
references: Blood Press Suppl. 2003 Dec;2:35-40
references: 14761075
references: Am J Hypertens. 2000 Jan;13(1 Pt 1):92-8
references: 10678277
references: J Hypertens. 1997 Jan;15(1):3-17
references: 9050965
references: Hypertension. 2000 Mar;35(3):807-13
references: 10720599
references: J Hypertens. 2008 Oct;26(10):1891-900
references: 18806611
references: J Am Heart Assoc. 2012 Oct;1(5):e002832
references: 23316296
references: Am J Cardiol. 2012 Mar 1;109(5):685-92
references: 22169130
references: Curr Hypertens Rep. 2001 Sep;3 Suppl 1:S3-9
references: 11580882
references: Diabetologia. 2007 Jan;50(1):186-94
references: 17096116
references: Diabetologia. 2012 May;55(5):1283-90
references: 22286552
references: Eur Heart J. 2008 May;29(10):1327-34
references: 18375982
references: Hypertension. 1999 Mar;33(3):769-74
references: 10082485
references: Diabetes Care. 2011 Aug;34(8):1833-7
references: 21680727
references: Arch Intern Med. 2002 Nov 11;162(20):2313-21
references: 12418945
references: Arch Intern Med. 2007 Oct 22;167(19):2116-21
references: 17954807